Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β- carboline

Thomas A. Sontag, Klaus W. Lange, Christine Marcelle Heim, Waclav Kolasiewicz, Oliver Tucha, Karl Heinz Sontag

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) is neurotoxic when administered to the brain and alters motor behaviour following intraperitoneal administration. We have assessed the long-term effects of oral TaClo administration on nocturnal motor behaviour in rats. Two groups of rats received TaClo orally at a dose of either 0.2 or 0.4 mg/kg twice daily for 7 weeks. The control group was given saline. No change in locomotor activity was observed 4-9 days after the end of the 7-week administration of TaClo. In addition, the spontaneous motor activity was altered dose-dependently 9 months after oral TaClo administration, with an increase in the low-dose TaClo group and a decrease in the high-dose group. Oral administration of TaClo in rats may be useful in investigating the hypothesis that in Parkinson's disease, an unknown pathogenic factor crossing the intestinal mucosa barrier can induce neurodegenerative processes eventually affecting the entire brain.

Original languageEnglish (US)
Pages (from-to)1267-1271
Number of pages5
JournalJournal of Neural Transmission
Volume116
Issue number10
DOIs
StatePublished - Oct 1 2009

Fingerprint

Carbolines
Neurotoxins
Oral Administration
Brain
Locomotion
Intestinal Mucosa
Parkinson Disease
Motor Activity
Control Groups

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Sontag, Thomas A. ; Lange, Klaus W. ; Heim, Christine Marcelle ; Kolasiewicz, Waclav ; Tucha, Oliver ; Sontag, Karl Heinz. / Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β- carboline. In: Journal of Neural Transmission. 2009 ; Vol. 116, No. 10. pp. 1267-1271.
@article{1be877d410ed4e8f8320e3c59375bc22,
title = "Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β- carboline",
abstract = "1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) is neurotoxic when administered to the brain and alters motor behaviour following intraperitoneal administration. We have assessed the long-term effects of oral TaClo administration on nocturnal motor behaviour in rats. Two groups of rats received TaClo orally at a dose of either 0.2 or 0.4 mg/kg twice daily for 7 weeks. The control group was given saline. No change in locomotor activity was observed 4-9 days after the end of the 7-week administration of TaClo. In addition, the spontaneous motor activity was altered dose-dependently 9 months after oral TaClo administration, with an increase in the low-dose TaClo group and a decrease in the high-dose group. Oral administration of TaClo in rats may be useful in investigating the hypothesis that in Parkinson's disease, an unknown pathogenic factor crossing the intestinal mucosa barrier can induce neurodegenerative processes eventually affecting the entire brain.",
author = "Sontag, {Thomas A.} and Lange, {Klaus W.} and Heim, {Christine Marcelle} and Waclav Kolasiewicz and Oliver Tucha and Sontag, {Karl Heinz}",
year = "2009",
month = "10",
day = "1",
doi = "10.1007/s00702-009-0261-6",
language = "English (US)",
volume = "116",
pages = "1267--1271",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer Verlag",
number = "10",

}

Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β- carboline. / Sontag, Thomas A.; Lange, Klaus W.; Heim, Christine Marcelle; Kolasiewicz, Waclav; Tucha, Oliver; Sontag, Karl Heinz.

In: Journal of Neural Transmission, Vol. 116, No. 10, 01.10.2009, p. 1267-1271.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β- carboline

AU - Sontag, Thomas A.

AU - Lange, Klaus W.

AU - Heim, Christine Marcelle

AU - Kolasiewicz, Waclav

AU - Tucha, Oliver

AU - Sontag, Karl Heinz

PY - 2009/10/1

Y1 - 2009/10/1

N2 - 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) is neurotoxic when administered to the brain and alters motor behaviour following intraperitoneal administration. We have assessed the long-term effects of oral TaClo administration on nocturnal motor behaviour in rats. Two groups of rats received TaClo orally at a dose of either 0.2 or 0.4 mg/kg twice daily for 7 weeks. The control group was given saline. No change in locomotor activity was observed 4-9 days after the end of the 7-week administration of TaClo. In addition, the spontaneous motor activity was altered dose-dependently 9 months after oral TaClo administration, with an increase in the low-dose TaClo group and a decrease in the high-dose group. Oral administration of TaClo in rats may be useful in investigating the hypothesis that in Parkinson's disease, an unknown pathogenic factor crossing the intestinal mucosa barrier can induce neurodegenerative processes eventually affecting the entire brain.

AB - 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) is neurotoxic when administered to the brain and alters motor behaviour following intraperitoneal administration. We have assessed the long-term effects of oral TaClo administration on nocturnal motor behaviour in rats. Two groups of rats received TaClo orally at a dose of either 0.2 or 0.4 mg/kg twice daily for 7 weeks. The control group was given saline. No change in locomotor activity was observed 4-9 days after the end of the 7-week administration of TaClo. In addition, the spontaneous motor activity was altered dose-dependently 9 months after oral TaClo administration, with an increase in the low-dose TaClo group and a decrease in the high-dose group. Oral administration of TaClo in rats may be useful in investigating the hypothesis that in Parkinson's disease, an unknown pathogenic factor crossing the intestinal mucosa barrier can induce neurodegenerative processes eventually affecting the entire brain.

UR - http://www.scopus.com/inward/record.url?scp=70349236920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349236920&partnerID=8YFLogxK

U2 - 10.1007/s00702-009-0261-6

DO - 10.1007/s00702-009-0261-6

M3 - Article

C2 - 19609633

AN - SCOPUS:70349236920

VL - 116

SP - 1267

EP - 1271

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 10

ER -